News
)
13 June 2023
Gurutz Linazasoro, CEO of VIVEbiotech, participates in the Foro de Biociencia
Gurutz Linazasoro, CEO of VIVEbiotech, will participate tomorrow in a round table discussion entitled "Boosting science and research of high quality and impact" at the...
Read more)
4 June 2023
VIVEbiotech has successfully participated in 5 international congresses in the first half of the year
VIVEbiotech has successfully participated in 5 international congresses in the first half of the year.
Read more)
18 May 2023
Article in RegMedNet about lentiviral vectors development and manufacturing challenges
Natalia Elizalde was interviewed at the Phacilitate's Advanced Therapies Week that took place in Miami in January this year.
Read more)
18 May 2023
VIVEbiotech collaborates with Gyros Protein Technologies in two Gyrolab Technology Seminars
Bárbara Rodríguez-Urretavizcaya, Analytical Development Scientist, has presented at two Gyrolab Technology Seminars.
Read more)
10 March 2023
Video-interview by The Medicine Maker
Natalia Elizalde was video-interviewed by The Medicine Maker during Phacilitate´s Advanced Therapies Week that took place in Miami in January.
Read more)
2 March 2023
Scrip reports on the predictions of VIVEbiotech
Natalia Elizalde has been included in the clinical trial section about the leading annual article series by Scrip alongside a number of leading international figures...
Read more)
17 February 2023
Gurutz Linazasoro, CEO of VIVEbiotech, participates at Transfiere
Gurutz Linazasoro, CEO of VIVEbiotech and coordinator of the AseBio´s, the Spanish Bioindustry Association ´s, advanced therapies working group, participated yesterday in a round...
Read more)
30 January 2023
VIVEbiotech interview on Labiotech.eu from Florida
Labiotech.eu interviewed Natalia Elizalde during Phacilitate’s Advanced Therapies Week congress that took place last week in Miami Beach, Florida.
Read more)
26 January 2023
VIVEbiotech featured in a Drug Discovery World guide
Natalia Elizalde and Naiara Tejados have participated in a Drug Discovery World cell and gene therapy guide that was recently published.
Read more)
9 January 2023
Article on lentiviral vector therapies in-vivo and ex-vivo in The Medicine Maker
Naiara Tejados, Head of Marketing and Technology Development, has published an article in The Medicine Maker entitled “Know Your Vectors: a 101 on Lentiviral Therapies”.
Read moreDestacadas
)
)
)
)
)
)
)
)
)
23 August 2024
)